Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to Assess the effect of MTA and hard setting Calcium Hydroxide (Dycal) on the clinical and radiographic outcome of direct pulp capping in primary molars and evaluate overall success rate of direct pulp capping in primary molars.


Clinical Trial Description

After informed consent, baseline clinical and radiographic assessment will be obtained and recorded in patient examination sheet. Participants who met the inclusion criteria were randomly allocated to two groups (n = 26/group, N = 52 in total) according to the capping martials using the envelope randomization method. 2 study groups according to capping material that will be used (Dycal or MTA) and each group will be divided to 2 subgroups according to site of exposure axial or pulpal. All patients were recalled and their treated molars were evaluated clinically and radiographically at 3months, 6months, 9months ,12months follow up periods. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05530954
Study type Interventional
Source Mansoura University
Contact
Status Completed
Phase Phase 3
Start date January 1, 2022
Completion date June 6, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04488679 - Clinical and Radiographic Assessment of Platelet Rich Fibrin and Mineral Trioxide Aggregate as Pulp Capping Biomaterials N/A
Completed NCT05167123 - Pulp Capping in Primary Molars Using TheraCal (LC) Phase 4
Terminated NCT01066533 - Immunohistochemical Study of Human Teeth Pulp Capped With Mineral Trioxide Aggregate (MTA) and Novel Endodontic Cement (NEC) Phase 4
Active, not recruiting NCT05496257 - Calcium Hydroxide Versus Premixed Bioceramic Putty in Direct Pulp Capping of Primary Molars N/A
Completed NCT05297344 - Clinical Study of the Direct Pulp Capping in Primary Teeth N/A